TGTX
TG Therapeutics Inc
Price:  
16.71 
USD
Volume:  
1,298,084.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TGTX Relative Valuation

-65.2%
Upside

As of 2024-05-27, the Relative Valuation of TG Therapeutics Inc (TGTX) is 5.81 USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.71 USD, the upside of TG Therapeutics Inc based on Relative Valuation is -65.2%.

The range of the Relative Valuation is 1.88 - 11.62 USD.

Range Selected
Trailing P/E multiples 29.3x - 43.6x 36.4x
Forward P/E multiples 27.8x - 28.5x 28.2x
Fair Price 1.88 - 11.62 5.81
Upside -88.7% - -30.5% -65.2%
16.71 USD
Stock Price
5.81 USD
Fair Price

TGTX Relative Valuation - Historical P/E Data

Date P/E
2024-05-24 62.71
2024-05-23 63.73
2024-05-22 66.43
2024-05-21 62.30
2024-05-20 61.85
2024-05-17 61.85
2024-05-16 65.38
2024-05-15 66.50
2024-05-14 67.41
2024-05-13 65.00
2024-05-10 62.38
2024-05-09 63.50
2024-05-08 64.25
2024-05-07 64.48
2024-05-06 61.96
2024-05-03 60.76
2024-05-02 61.63
2024-05-01 59.60
2024-04-30 51.27
2024-04-29 49.99
2024-04-26 50.55
2024-04-25 52.21
2024-04-24 52.47
2024-04-23 53.48
2024-04-22 52.92
2024-04-19 51.72
2024-04-18 52.51
2024-04-17 51.87
2024-04-16 52.54
2024-04-15 52.81
2024-04-12 53.14
2024-04-11 55.40
2024-04-10 55.21
2024-04-09 56.67
2024-04-08 56.18
2024-04-05 54.49
2024-04-04 54.27
2024-04-03 54.31
2024-04-02 54.19
2024-04-01 55.43
2024-03-28 57.08
2024-03-27 58.44
2024-03-26 57.95
2024-03-25 58.89
2024-03-22 58.13
2024-03-21 57.23
2024-03-20 57.68
2024-03-19 57.53
2024-03-18 56.48
2024-03-15 57.12